Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SHANDONG LUYE PHARMACEUTICAL CO LTD

  • FDA Approval
  • Jan. 17, 2023, 21:41 UTC
  • 27
  • 0 comments

FDA approve RISERIDONE

Comment Full text

BRISTOL

  • FDA Approval
  • Jan. 17, 2023, 21:24 UTC
  • 26
  • 0 comments

FDA approve MAVACAMTEN

Comment Full text

ALMATICA

  • FDA Approval
  • Jan. 17, 2023, 21:10 UTC
  • 27
  • 0 comments

FDA approve LORAZEPAM

Comment Full text

NOVARTIS

  • FDA Approval
  • Jan. 17, 2023, 19:26 UTC
  • 25
  • 0 comments

FDA approve DEFERASIROX

Comment Full text

IPR

  • FDA Approval
  • Jan. 17, 2023, 19:23 UTC
  • 25
  • 0 comments

FDA approve ROSUVASTATIN CALCIUM

Comment Full text

IPR

  • FDA Approval
  • Jan. 17, 2023, 19:23 UTC
  • 25
  • 0 comments

FDA approve ROSUVASTATIN CALCIUM

Comment Full text

UPJOHN

  • FDA Approval
  • Jan. 17, 2023, 19:19 UTC
  • 29
  • 0 comments

FDA approve ALPRAZOLAM

Comment Full text

SPECGX LLC

  • FDA Approval
  • Jan. 17, 2023, 19:16 UTC
  • 26
  • 0 comments

FDA approve TEMAZEPAM

Comment Full text

OTTER PHARMS

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 20
  • 0 comments

FDA approve CLOBAZAM

Comment Full text

MMT

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 24
  • 0 comments

FDA approve MIDAZOLAM HYDROCHLORIDE

Comment Full text
  • Previous
  • 900
  • 901
  • 902
  • 903
  • 904
  • Next

Search

News categories

  • Technical Exchange News(12261)
  • Event(6229)
  • SEC News(265580)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(155180)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin